Torrent Pharma Tapentadol Nasal Spray gets CDSCO panel go ahead for phase 3 trial Medical Dialogues Team17 Aug 2021 3:40 PM ISTNew Delhi: The Ahmedabad-based pharmaceutical major, Torrent Pharma, has received permission from the Subject Expert Committee (SEC) of the Central...
Sun Pharma gets CDSCO panel nod to additional pack size of Gemcitabine Medical Dialogues Team16 Aug 2021 2:00 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
Glenmark gets CDSCO panel nod for manufacturing, marketing Itraconazole Capsules Medical Dialogues Team15 Aug 2021 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has given its nod to pharma major Glenmark...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 3:25 PM ISTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Pfizer Tafamidis to be sold on prescription of cardiologist only: CDSCO panel Medical Dialogues Team10 Aug 2021 5:24 PM ISTNew Delhi: Granting the permission of local clinical trial waver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Setback: Mylan proposal for Hydroxychloroquine Sulfate Tablet rejected by CDSCO panel Medical Dialogues Team6 Aug 2021 1:02 PM ISTNew Delhi: In a major setback to Mylan Laboratories, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Sun Pharma Progesterone injection secures CDSCO panel okay Medical Dialogues Team5 Aug 2021 5:52 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Revise clinical trial protocol for Remdesivir powder for inhalation: CDSCO panel tells Lupin Medical Dialogues Team4 Aug 2021 4:00 PM ISTNew Delhi: In response to the drug maker Lupin's proposal to conduct a PhaseII/III Clinical Trial protocol for Remdesivir Powder for Inhalation,...
Provide more safety, immunogenicity data: CDSCO panel tells Biological E on trial of COVID vaccine Medical Dialogues Team3 Aug 2021 3:50 PM ISTNew Delhi: Following the proposal presented by Biological E to conduct a Phase II/III clinical trial of its Covid-19 vaccine containing the SARSCoV-2...
Macleods Pharma gets CDSCO panel nod to conduct clinical trial of Amikacin Sulphate Gel Medical Dialogues Team1 Aug 2021 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Present clinical trial, pharmacokinetic data of antiparasitic drug Tafenoquine: CDSCO panel tells GSK Medical Dialogues Team31 July 2021 10:30 AM ISTNew Delhi: Seeking justification for Phase III Clinical Trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
